USSTOCK.TODAY
After-Market
Log in Sign up

Myriad Genetics beats revenue and loss per share estimates

Earnings Whispers +1 · ·by G4L

MYGN
MYGN Myriad Genetics Inc
$5.74 -3.04%
View chart & analysis →
  1. 1Myriad Genetics recorded $20.7 million in revenue for the second quarter.
  2. 2Myriad Genetics' second-quarter loss per share was 16.0% better than consensus.
  3. 3Labcorp agreed to pay $210 million in cash and inventory.

So what's the key point?

What is the main point? Myriad Genetics earned more money than expected. The loss was 16.0% lower than what experts predicted.

Source Earnings Whispers +1 · View original ↗

Related 3-line summaries

Myriad Genetics to sell prenatal health business to LabCorp for $210 million The Motley Fool +1 · 3d agoMyriad Genetics to sell prenatal health testing business to Labcorp for $210 million Nasdaq +1 · Oct 21Amazon Winds Down Most of Its Core Nova Models in AI Strategy Overhaul Reuters +5 · Jul 29
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news